A citation-based method for searching scientific literature


List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.
M William Audeh, James Carmichael, Richard T Penson, Michael Friedlander, Bethan Powell, Katherine M Bell-McGuinn, Clare Scott, Jeffrey N Weitzel, Ana Oaknin, Niklas Loman,[...]. Lancet 2010
952
40

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
40

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005
40

BRCA1 gene: function and deficiency.
Miho Takaoka, Yoshio Miki. Int J Clin Oncol 2018
41
40

Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.
Junko Murai, Shar-yin N Huang, Benu Brata Das, Amelie Renaud, Yiping Zhang, James H Doroshow, Jiuping Ji, Shunichi Takeda, Yves Pommier. Cancer Res 2012
40


Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
Helen E Bryant, Niklas Schultz, Huw D Thomas, Kayan M Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J Curtin, Thomas Helleday. Nature 2005
40

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.
Bella Kaufman, Ronnie Shapira-Frommer, Rita K Schmutzler, M William Audeh, Michael Friedlander, Judith Balmaña, Gillian Mitchell, Georgeta Fried, Salomon M Stemmer, Ayala Hubert,[...]. J Clin Oncol 2015
40

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
40

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.
Eric Pujade-Lauraine, Jonathan A Ledermann, Frédéric Selle, Val Gebski, Richard T Penson, Amit M Oza, Jacob Korach, Tomasz Huzarski, Andrés Poveda, Sandro Pignata,[...]. Lancet Oncol 2017
752
40


Genetic susceptibility to breast cancer.
Nasim Mavaddat, Antonis C Antoniou, Douglas F Easton, Montserrat Garcia-Closas. Mol Oncol 2010
211
20

BRCA1/2 mutations and triple negative breast cancers.
Beth N Peshkin, Michelle L Alabek, Claudine Isaacs. Breast Dis 2010
77
20

Cancer predisposing BARD1 mutations in breast-ovarian cancer families.
Magdalena Ratajska, Ewelina Antoszewska, Anna Piskorz, Izabela Brozek, Åke Borg, Hanna Kusmierek, Wojciech Biernat, Janusz Limon. Breast Cancer Res Treat 2012
63
20

Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer.
Duan-Jun Tan, Ren-Kui Bai, Lee-Jun C Wong. Cancer Res 2002
196
20

Association analysis identifies 65 new breast cancer risk loci.
Kyriaki Michailidou, Sara Lindström, Joe Dennis, Jonathan Beesley, Shirley Hui, Siddhartha Kar, Audrey Lemaçon, Penny Soucy, Dylan Glubb, Asha Rostamianfar,[...]. Nature 2017
505
20

Expanded extracolonic tumor spectrum in MUTYH-associated polyposis.
Stefanie Vogt, Natalie Jones, Daria Christian, Christoph Engel, Maartje Nielsen, Astrid Kaufmann, Verena Steinke, Hans F Vasen, Peter Propping, Julian R Sampson,[...]. Gastroenterology 2009
170
20

MutYH mutation carriers have increased breast cancer risk.
Gad Rennert, Flavio Lejbkowicz, Ilana Cohen, Mila Pinchev, Hedy S Rennert, Ofra Barnett-Griness. Cancer 2012
38
20

Cancer risks among BRCA1 and BRCA2 mutation carriers.
E Levy-Lahad, E Friedman. Br J Cancer 2007
208
20

Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
Weizhu Zhu, Wenyi Qin, Paul Bradley, Amy Wessel, Charles L Puckett, Edward R Sauter. Carcinogenesis 2005
99
20

Epidemiological study of high cancer among rural agricultural community of Punjab in Northern India.
J S Thakur, B T Rao, Arvind Rajwanshi, H K Parwana, Rajesh Kumar. Int J Environ Res Public Health 2008
23
20

Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer.
Marijke Wasielewski, Astrid A Out, Joyce Vermeulen, Maartje Nielsen, Ans van den Ouweland, Carli M J Tops, Juul T Wijnen, Hans F A Vasen, Marjan M Weiss, Jan G M Klijn,[...]. Breast Cancer Res Treat 2010
28
20

Lynch syndrome caused by MLH1 mutations is associated with an increased risk of breast cancer: a cohort study.
Elaine F Harkness, Emma Barrow, Katy Newton, Kate Green, Tara Clancy, Fiona Lalloo, James Hill, D Gareth Evans. J Med Genet 2015
44
20

Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example.
Katarzyna Klonowska, Magdalena Ratajska, Karol Czubak, Alina Kuzniacka, Izabela Brozek, Magdalena Koczkowska, Marcin Sniadecki, Jaroslaw Debniak, Dariusz Wydra, Magdalena Balut,[...]. Sci Rep 2015
23
20

Ten new ATM alterations in Polish patients with ataxia-telangiectasia.
Marta Joanna Podralska, Agnieszka Stembalska, Ryszard Ślęzak, Aleksandra Lewandowicz-Uszyńska, Barbara Pietrucha, Sylwia Kołtan, Jadwiga Wigowska-Sowińska, Jacek Pilch, Maria Mosor, Iwona Ziółkowska-Suchanek,[...]. Mol Genet Genomic Med 2014
14
20

Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers.
Yen-Li Lo, Chin-Fu Hsiao, Yuh-Shan Jou, Gee-Chen Chang, Ying-Huang Tsai, Wu-Chou Su, Kuan-Yu Chen, Yuh-Min Chen, Ming-Shyan Huang, Wan-Shan Hsieh,[...]. Lung Cancer 2011
38
20

BRCA2 mutations and triple-negative breast cancer.
Peter Meyer, Katharina Landgraf, Bernhard Högel, Wolfgang Eiermann, Beyhan Ataseven. PLoS One 2012
29
20


Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
259
20

Familial breast cancer.
F Lalloo, D G Evans. Clin Genet 2012
98
20

Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.
Sunita Saxena, Anurupa Chakraborty, Mishi Kaushal, Sanjeev Kotwal, Dinesh Bhatanager, Ravindar S Mohil, Chintamani Chintamani, Anil K Aggarwal, Veena K Sharma, Prakash C Sharma,[...]. BMC Med Genet 2006
61
20

Polymorphisms in the MTHFR gene are associated with breast cancer.
Emel Ergul, Ali Sazci, Zafer Utkan, N Zafer Canturk. Tumour Biol 2003
75
20

Folate and carcinogenesis: developing a unifying hypothesis.
J B Mason, S W Choi. Adv Enzyme Regul 2000
61
20


Cancer risks and mortality in heterozygous ATM mutation carriers.
Deborah Thompson, Silvia Duedal, Jennifer Kirner, Lesley McGuffog, James Last, Anne Reiman, Philip Byrd, Malcolm Taylor, Douglas F Easton. J Natl Cancer Inst 2005
325
20

Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.
Cezary Cybulski, Dominika Wokołorczyk, Anna Jakubowska, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Bartłomiej Masojć, Tadeusz Deebniak, Bohdan Górski, Paweł Blecharz,[...]. J Clin Oncol 2011
130
20

BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation.
Kannan Vaidyanathan, Smita Lakhotia, H M Ravishankar, Umaira Tabassum, Geetashree Mukherjee, Kumaravel Somasundaram. J Biosci 2009
38
20

CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.
Maren Weischer, Stig Egil Bojesen, Christina Ellervik, Anne Tybjaerg-Hansen, Børge Grønne Nordestgaard. J Clin Oncol 2008
184
20

Comparing the metal concentration in the hair of cancer patients and healthy people living in the malwa region of punjab, India.
Eleonore Blaurock-Busch, Yvette M Busch, Albrecht Friedle, Holger Buerner, Chander Parkash, Anudeep Kaur. Clin Med Insights Oncol 2014
25
20

Breast cancer susceptibility: current knowledge and implications for genetic counselling.
Tim Ripperger, Dorothea Gadzicki, Alfons Meindl, Brigitte Schlegelberger. Eur J Hum Genet 2009
131
20

Current perspectives on CHEK2 mutations in breast cancer.
Panagiotis Apostolou, Ioannis Papasotiriou. Breast Cancer (Dove Med Press) 2017
44
20

BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families.
Dace Berzina, Miki Nakazawa-Miklasevica, Jekaterina Zestkova, Karina Aksenoka, Arvids Irmejs, Andris Gardovskis, Dagnija Kalniete, Janis Gardovskis, Edvins Miklasevics. BMC Med Genet 2013
8
20

Pesticide residues in human breast milk: risk assessment for infants from Punjab, India.
J S Bedi, J P S Gill, R S Aulakh, P Kaur, A Sharma, P A Pooni. Sci Total Environ 2013
45
20

An association study between CHEK2 gene mutations and susceptibility to breast cancer.
Manizheh Jalilvand, Mana Oloomi, Reza Najafipour, Safar Ali Alizadeh, Najmaldin Saki, Fatemeh Samiee Rad, Mohammad Shekari. Comp Clin Path 2017
8
20

Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations.
Konstantin J Dedes, Paul M Wilkerson, Daniel Wetterskog, Britta Weigelt, Alan Ashworth, Jorge S Reis-Filho. Cell Cycle 2011
111
20

Folic acid deficiency increases chromosomal instability, chromosome 21 aneuploidy and sensitivity to radiation-induced micronuclei.
Sasja Beetstra, Philip Thomas, Carolyn Salisbury, Julie Turner, Michael Fenech. Mutat Res 2005
115
20

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.
Alfons Meindl, Heide Hellebrand, Constanze Wiek, Verena Erven, Barbara Wappenschmidt, Dieter Niederacher, Marcel Freund, Peter Lichtner, Linda Hartmann, Heiner Schaal,[...]. Nat Genet 2010
459
20

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.
Julie Lecarpentier, Valentina Silvestri, Karoline B Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Penny Soucy, Goska Leslie, Piera Rizzolo, Anna Sara Navazio,[...]. J Clin Oncol 2017
81
20

A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2-Mutated Ovarian Carcinoma or Other Solid Tumors.
Rebecca Kristeleit, Geoffrey I Shapiro, Howard A Burris, Amit M Oza, Patricia LoRusso, Manish R Patel, Susan M Domchek, Judith Balmaña, Yvette Drew, Lee-May Chen,[...]. Clin Cancer Res 2017
130
20

Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors.
Maria Teresa Esposito, Lu Zhao, Tsz Kan Fung, Jayant K Rane, Amanda Wilson, Nadine Martin, Jesus Gil, Anskar Y Leung, Alan Ashworth, Chi Wai Eric So. Nat Med 2015
97
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.